Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | RP11-886H22.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | PIK3R3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | MMD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ACBD7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | C1QTNF3-AMACR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | LFNG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | C11orf95 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | ZNF423 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | KANSL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |